Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Australia
0
South Africa
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. H 168 68
2. H 168-68
3. H 16868
4. Magnesium, Omeprazole
5. Omeprazole
6. Omeprazole Magnesium
7. Omeprazole Sodium
8. Prilosec
9. Sodium, Omeprazole
1. Omeprazole Magnesium
2. 95382-33-5
3. Magnesium;6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1h-benzimidazole
Molecular Weight | 715.1 g/mol |
---|---|
Molecular Formula | C34H38MgN6O6S2+2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 10 |
Exact Mass | 714.2144670 g/mol |
Monoisotopic Mass | 714.2144670 g/mol |
Topological Polar Surface Area | 193 Ų |
Heavy Atom Count | 49 |
Formal Charge | 2 |
Complexity | 453 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Omeprazole magnesium |
Drug Label | 11 DESCRIPTIONThe active ingredient in PRILOSEC (omeprazole) Delayed-Release Capsules is a substituted benzimidazole, 5-methoxy-2-[[(4-methoxy-3, 5-dimethyl-2-pyridinyl) methyl] sulfinyl]-1H-benzimidazole, a compound that inhibits gastric acid secret... |
Active Ingredient | Omeprazole magnesium |
Dosage Form | Capsule, delayed release |
Route | Oral |
Strength | eq 20mg base |
Market Status | Over the Counter |
Company | Dr Reddys Labs |
2 of 2 | |
---|---|
Drug Name | Omeprazole magnesium |
Drug Label | 11 DESCRIPTIONThe active ingredient in PRILOSEC (omeprazole) Delayed-Release Capsules is a substituted benzimidazole, 5-methoxy-2-[[(4-methoxy-3, 5-dimethyl-2-pyridinyl) methyl] sulfinyl]-1H-benzimidazole, a compound that inhibits gastric acid secret... |
Active Ingredient | Omeprazole magnesium |
Dosage Form | Capsule, delayed release |
Route | Oral |
Strength | eq 20mg base |
Market Status | Over the Counter |
Company | Dr Reddys Labs |
Proton Pump Inhibitors
Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX. (See all compounds classified as Proton Pump Inhibitors.)
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
A Omeprazole Magnesium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Omeprazole Magnesium, including repackagers and relabelers. The FDA regulates Omeprazole Magnesium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Omeprazole Magnesium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Omeprazole Magnesium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Omeprazole Magnesium supplier is an individual or a company that provides Omeprazole Magnesium active pharmaceutical ingredient (API) or Omeprazole Magnesium finished formulations upon request. The Omeprazole Magnesium suppliers may include Omeprazole Magnesium API manufacturers, exporters, distributors and traders.
click here to find a list of Omeprazole Magnesium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Omeprazole Magnesium DMF (Drug Master File) is a document detailing the whole manufacturing process of Omeprazole Magnesium active pharmaceutical ingredient (API) in detail. Different forms of Omeprazole Magnesium DMFs exist exist since differing nations have different regulations, such as Omeprazole Magnesium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Omeprazole Magnesium DMF submitted to regulatory agencies in the US is known as a USDMF. Omeprazole Magnesium USDMF includes data on Omeprazole Magnesium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Omeprazole Magnesium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Omeprazole Magnesium suppliers with USDMF on PharmaCompass.
A Omeprazole Magnesium CEP of the European Pharmacopoeia monograph is often referred to as a Omeprazole Magnesium Certificate of Suitability (COS). The purpose of a Omeprazole Magnesium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Omeprazole Magnesium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Omeprazole Magnesium to their clients by showing that a Omeprazole Magnesium CEP has been issued for it. The manufacturer submits a Omeprazole Magnesium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Omeprazole Magnesium CEP holder for the record. Additionally, the data presented in the Omeprazole Magnesium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Omeprazole Magnesium DMF.
A Omeprazole Magnesium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Omeprazole Magnesium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Omeprazole Magnesium suppliers with CEP (COS) on PharmaCompass.
A Omeprazole Magnesium written confirmation (Omeprazole Magnesium WC) is an official document issued by a regulatory agency to a Omeprazole Magnesium manufacturer, verifying that the manufacturing facility of a Omeprazole Magnesium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Omeprazole Magnesium APIs or Omeprazole Magnesium finished pharmaceutical products to another nation, regulatory agencies frequently require a Omeprazole Magnesium WC (written confirmation) as part of the regulatory process.
click here to find a list of Omeprazole Magnesium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Omeprazole Magnesium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Omeprazole Magnesium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Omeprazole Magnesium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Omeprazole Magnesium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Omeprazole Magnesium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Omeprazole Magnesium suppliers with NDC on PharmaCompass.
Omeprazole Magnesium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Omeprazole Magnesium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Omeprazole Magnesium GMP manufacturer or Omeprazole Magnesium GMP API supplier for your needs.
A Omeprazole Magnesium CoA (Certificate of Analysis) is a formal document that attests to Omeprazole Magnesium's compliance with Omeprazole Magnesium specifications and serves as a tool for batch-level quality control.
Omeprazole Magnesium CoA mostly includes findings from lab analyses of a specific batch. For each Omeprazole Magnesium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Omeprazole Magnesium may be tested according to a variety of international standards, such as European Pharmacopoeia (Omeprazole Magnesium EP), Omeprazole Magnesium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Omeprazole Magnesium USP).
LOOKING FOR A SUPPLIER?